Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 119-126

  Kontush, Anatol ^a   Reich, Axel ^a   Baum, Katja ^a   Spranger, Torsten ^a   Finckh, Barbara ^a   Kohlschütter, Alfried ^a   Beisiegel, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

atherosclerosis; coronary heart disease; hyperlipidaemia; hypertension; lipid peroxidation; liver disease; smoking; ubiquinol 10

Indexed keywords

UBIQUINOL 10; UBIQUINONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING;

ADULT; ALCOHOL DRINKING; AMIDINES; ANTIDOTES; BODY MASS INDEX; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIPID PEROXIDATION; LIPOXYGENASE; LIVER DISEASES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SPECTROPHOTOMETRY; TRIGLYCERIDES; UBIQUINONE;

EID: 0031047276     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06021-2     Document Type: Article

References (37)

1. Mitchell P, Moyle J. The role of ubiquinone and plastoquinone in chemiosmotic coupling between electron transfer and proton translocation. In: Lenaz G. (ed). Coenzyme Q. Chichester: Wiley, 1985;145.
2. Frei B, Kim MC, Ames B. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 1990;87:4879.
3. Ernster L, Forsmark-Andree P. Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin Invest 1993;71:S60.
4. Karlsson J, Diamant B, Theorell H, Folkers K. Ubiquinone and α-tocopherol in plasma; means of translocation or depot. Clin Invest 1993;71:S84.
5. 10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 1988;425:87.
6. Okamoto T, Matsuya T, Fukunaga Y, Kishi T, Yamagami T. Human serum ubiquinol-10 levels and relationship to serum lipids. Int J Vit Nutr Res 1989;59:288.
7. Aberg F, Appelkvist E-L, Dallner G, Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys 1992;295:230.
8. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 1991;88:1646.
9. 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta 1992;1126:247.
10. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. Antioxidant activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. Biochim Biophys Acta 1995;1258:177.
11. Matsura T, Yamada K, Kawasaki T. Antioxidant role of cellular reduced coenzyme Q homologs and α-tocopherol in free radical-induced injury of hepatocytes isolated from rats fed diets with different vitamin E contents. Biochim Biophys Acta 1992;1127:277.
12. Gutteridge JMC. Free radicals in disease processes: a compilation of cause and consequence. Free Radic Res Commun 1993;19:141.
13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320: 915.
14. Maggi E, Marchesi E, Ravetta V, Falaschi F, Finardi G, Bellomo G. Low-density lipoprotein oxidation in essential hypertension. J Hypertens 1993;11:1103.
15. Finckh B, Kontush A, Commentz A, Hübner C, Burdelski M, Kohlschütter A. Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 1995;232:210.
16. Kontush A, Meyer S, Finckh B, Kohlschütter A, Beisiegel U. α-Tocopherol as a reductant for Cu(II) in human lipoproteins: triggering role in the initiation of lipoprotein oxidation. J Biol Chem 1996;271:11106.
17. Kontush A, Finckh B, Karten B, Kohlschütter A, Beisiegel U. Antioxidant and prooxidant activity of α-tocopherol in human plasma and low density lipoprotein. J Lipid Res 1996;37:1436.
18. 10 in human plasma as a possible marker of oxidative stress. J Lipid Res 1996;37:67.
19. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. Free Radic Res 1996;24:135.
20. Regnström J, Ström K, Moldeus P, Nilsson J. Analysis of lipoprotein diene formation in human serum exposed to copper. Free Radic Res Commun 1993;19:267.
21. Schnitzer E, Pinchul I, Fainaru M, Schafer Z, Lichtenberg D. Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochim Biophys Res Commun 1995;216:854.
22. Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993;115:6029.
23. Dudman NPB, Wilcken DEL, Stocker R. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia: relevance to development of arteriosclerosis. Arterioscler Thromb 1993;13:512.
24. Lemke M, Frei B, Ames BN, Faden A. Decreases in tissue levels of ubiquinol-9 and -10, ascorbate and α-tocopherol following spinal cord impact trauma in rats. Neurosci Lett 1990;108:201.
25. Hanaki Y, Sugiyama S, Ozawa T, Ohno M. Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor. N Engl J Med 1993;325:814.
26. Lavy A, Brook GJ, Dankner G, Amotz AM, Aviram M. Enhanced in vitro oxidation of plasma lipoprotein derived from hypercholesterolemic patients. Metabolism 1991;40:794.
27. Araujo FB, Barbosa DS, Hsin CY, Maranhao RC, Abdalla DSP. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis 1995;117:61.
28. Cominachini L, Garbin U, Pastorino AM et al. Predisposition to LDL oxidation in patients with or without angiographically established coronary artery disease. Atherosclerosis 1993;99:63.
29. Stalenhof AFH, Defesche JC, Kleinveld HA, Demacker PNM, Kastelein JJP. Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100. Atheroscler Thromb 1994;14:489.
30. Walzem RL, Watkins S, Frankel EN, Hansen RJ, German JB. Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Proc Natl Acad Sci USA 1995;92:7460.
31. Tribble DL. Lipoprotein oxidation in dyslipidemia: insights into general mechanisms affecting lipoprotein oxidative behaviour. Curr Opin Lipidol 1995;6:196.
32. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994;5:422.
33. Hazell L, Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 1993;290:165.
34. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915.
35. Leo MA, Rosman AS, Lieber CS. Differential depletion of carotenoids and tocopherol in liver disease. Hepatology 1993;17:977.
36. 2-isoprostanes) in smokers. N Engl J Med 1995;332:1198.
37. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57(Suppl):715S.